Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.65
-0.25 (-1.57%)
At close: Jul 29, 2026

Genomics BioSci & Tech. Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
738.4708.38517.58396.14419389.97
Revenue Growth
40.82%36.86%30.65%-5.46%7.45%-12.01%
Gross Profit
239.63231.36157.18119.91136.01109.92
Operating Income
-79.7-84.16-140.29-81.9-33.52-28.66
Net Income
-55.43-39.43-223.1-168.0771.618.74
Earnings Per Share
-0.77-0.54-3.08-2.361.130.31
EPS Growth
----267.48%3103.13%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Instrument Sales Department
196.24191.92----
Genetic Testing Department
544.67519.86517.58397.18419389.97
Adjustment and Eliminations
-2.51-3.4--1.03--
Total
738.4708.38517.58396.14419389.97

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
123.41172.9237.58253.03317107.5
Total Debt
640.75628.25507.67283.61228.8486.53
Net Cash (Debt)
-517.33-455.35-270.08-30.5888.1720.96
Net Cash Growth
----320.57%-95.42%
Net Cash Per Share
-7.14-6.29-3.73-0.431.390.35

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-87.93-86.79-111.77-96.02-21.13-27.76
Capital Expenditures
-35.16-73.49-193.62-150.26-94.08-93.59
Free Cash Flow
-123.09-160.28-305.39-246.28-115.21-121.35
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.45%32.66%30.37%30.27%32.46%28.19%
Operating Margin
-10.79%-11.88%-27.11%-20.67%-8.00%-7.35%
Pretax Margin
-11.33%-9.55%-45.47%-42.39%17.25%3.10%
Profit Margin
-7.51%-5.57%-43.10%-42.43%17.09%4.81%
FCF Margin
-16.67%-22.63%-59.00%-62.17%-27.50%-31.12%

Dividends

Fiscal YearFY 2022
Period EndingDec '22
Dividend Per Share
0.098
Dividend Per Share Growth
-
Dividend Yield
0.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----17.5660.09
PS Ratio
1.542.632.693.803.002.89